Literature DB >> 8396598

Response of hepatocellular carcinoma to percutaneous ethanol injection: CT and MR evaluation.

R Lencioni1, D Caramella, C Bartolozzi.   

Abstract

OBJECTIVE: The aim of the present study was to perform a comparative assessment of the contribution of imaging examinations to the evaluation of the response of hepatocellular carcinoma (HCC) to percutaneous ethanol injection (PEI).
MATERIALS AND METHODS: Twenty-five small HCCs (< 5 cm in diameter) were treated by means of PEI. The outcome of treatment, established on the basis of percutaneous biopsy and a 10 to 26 month follow-up, was complete necrosis in 23 of 25 cases and tumor persistence in 2 of 25.
RESULTS: While ultrasound proved to be unable to distinguish posttreatment fibrosis from persisting neoplastic tissue, contrast-enhanced CT correctly identified the two cases of treatment failure, which showed the presence of enhancing areas within the lesion. The remaining 23 cases displayed a hypodense appearance, with no contrast enhancement on CT. Magnetic resonance demonstrated ethanol-induced coagulative necrosis as marked hypointensity on T2-weighted images in 21 of 25 cases. In four cases areas of high signal intensity on T2-weighted images within the nodule were observed after PEI: In two cases they were associated with tumor persistence, and in the other two with the presence of liquefactive necrosis.
CONCLUSION: Our results demonstrate that different necrotic phenomena following ethanol injection therapy of HCCs may result in variable MR appearance. Although the location of hyperintense areas may suggest a differential diagnosis (central hyperintensity being more likely due to necrosis), CT remains the more reliable technique in the assessment of the response of HCC to PEI.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8396598     DOI: 10.1097/00004728-199309000-00011

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  7 in total

Review 1.  Ethanol injection for the treatment of hepatic tumours.

Authors:  C Bartolozzi; R Lencioni
Journal:  Eur Radiol       Date:  1996       Impact factor: 5.315

Review 2.  [Diagnosis and therapy of hepatocellular carcinoma].

Authors:  H Reinwald
Journal:  Med Klin (Munich)       Date:  1997-11-15

3.  Sonazoid-enhanced sonography for guiding radiofrequency ablation for hepatocellular carcinoma: better tumor visualization by Kupffer-phase imaging and vascular-phase imaging after reinjection.

Authors:  Noriyuki Miyamoto; Kazuhide Hiramatsu; Kazuhiko Tsuchiya; Yukihiko Sato; Satoshi Terae; Hiroki Shirato
Journal:  Jpn J Radiol       Date:  2009-06-06       Impact factor: 2.374

4.  Contrast-enhanced ultrasonography (CEUS) immediately after percutaneous ablation of hepatocellular carcinoma.

Authors:  A Gallotti; M D'Onofrio; A Ruzzenente; E Martone; R De Robertis; A Guglielmi; R Pozzi Mucelli
Journal:  Radiol Med       Date:  2009-09-05       Impact factor: 3.469

5.  Transcatheter arterial embolization followed by percutaneous ethanol injection in the treatment of hepatocellular carcinoma.

Authors:  R Lencioni; C Vignali; D Caramella; R Cioni; S Mazzeo; C Bartolozzi
Journal:  Cardiovasc Intervent Radiol       Date:  1994 Mar-Apr       Impact factor: 2.740

6.  Percutaneous ethanol injection for hepatocellular carcinoma: 20-year outcome and prognostic factors.

Authors:  Shuichiro Shiina; Ryosuke Tateishi; Masatoshi Imamura; Takuma Teratani; Yukihiro Koike; Shinpei Sato; Shuntaro Obi; Fumihiko Kanai; Naoya Kato; Haruhiko Yoshida; Masao Omata; Kazuhiko Koike
Journal:  Liver Int       Date:  2012-06-19       Impact factor: 5.828

7.  The Islanding effect - a special method of percutaneous peritumor ethanol injection for hepatocellular carcinoma: 15-year follow-up outcome.

Authors:  Ze-Wu Meng; Xin-Ran Cai; Chang-Zhao Lin; Yan-Ling Chen; Song Liu
Journal:  Medicine (Baltimore)       Date:  2021-01-22       Impact factor: 1.889

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.